QUALITY OF LIFE IN PATIENTS AFTER MASSIVE PULMONARY EMBOLISM
Abstract
Background. Pulmonary embolism is a disease, which has a 30% mortality if untreated, while an early diagnosis and treatment lowers it to 2–8%. Health related quality of life (HRQL) of patients who survived massive pulmonary embolism is unknown in published literature. In our research we tried to apply experience of foreign experts in estimation of quality of life in some other diseases to the field of massive pulmonary embolism.
Patients and methods. Eighteen patients with shock or hypotension due to massive pulmonary embolism, treated with thrombolysis, between July 1993 and November 2000, were prospectively included in the study. Control group included 18 gender and age matched persons. There were no significant differences regarding demographic data between the groups. The HRQL and aerobic capacity of patients and control group were tested with short questions and questionnaires (Veterans brief, self administered questionnaire (VSAQ), EuroQuality questionnaire (EQ), Living with heart failure questionnaire (LlhHF). With LlhHF physical (F-LlhHF) and emotional (E-LlhHF) HRQL was assessed at hospitalization and 12 months later.
Results. One year after massive pulmonary embolism aerobic capacity (–9.5%, p < 0.017) and HRQL (EQ (–34.5%), F-LlhHF (–85.4%), E-LlhHF (–48.7%)) decreased in massive pulmonary embolism group compared to aerobic capacity 6 months before massive pulmonary embolism and HRQL. Heart rate before thrombolysis correlated with aerobic capacity (r = 0.627, p < 0.01), EQ (r = 0.479, p < 0.01) and F-LlhHF (r = 0.479, p = 0.04) 1 year after massive pulmonary embolism. Total pulmonary resistance at 12 hours after start of treatment correlated with aerobic capacity at 1 year (r = 0.354, p < 0.01).
With short question (»Did you need any help in everyday activities in last 2 weeks?«) we successfully separated patients with decreased HRQL in EQ (74.3 ± 20.8 vs. 24.5 ± 20.7, p < 0.001) and F-LlhHF (21.7 ± 6.7 vs. 32.8 ± 4.3, p < 0.01), but we could not identify the patients with deminished aerobic capacity.
Conclusions. Aerobic capacity, emotional and physical quality of life is decreased one year after massive pulmonary embolism in patients treated with thrombolysis. A linear correlation between decrease in aerobic capacity and total pulmonary resistance after 12 hours of treatment was present.
Downloads
References
Anderson FA Jr, Wheeler HB, Goldberg RJ et al. A population-based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT Study. Arch Intern Med 1991; 151: 933–3.
Torbicki et al. Task force on pulmonary embolism. European Society of Cardiology. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 2000; 21: 1301–1.
Bergqvist D, Lindblad B. A 30-year survey of pulmonary embolism verified at autopsy: An analysis of 1274 surgical patients. Br J Surg 1985; 72: 105–5.
Goldhaber SZ, Hennekens CH, Evans DA et al. Factors associated with the correct antemortem diagnosis of major pulmonary embolism. Am J Med 1982; 73: 822–2.
Coon WW, Willis PW. Deep venous thrombosis and pulmonary embolism: Prediction, prevention and treatment. Am J Cardiol 1959; 4: 611–1.
Soloff LA, Rodman T. Acute pulmonary embolism. Am Heart J 1967; 74: 829–9.
Nixdorf U, Erbel R, Drexler M et al. Detection of thrombembolus of right pulmonary artery by transesophageal two-dimensional echocardiography. Am J Cardiol 1988; 61: 488–9.
Krivec B, Voga G, Žuran I, Skale R, Parežnik R, Podbregar M, Noč M. Diagnosis and treatment of shock due to massive pulmonary embolism: approach with transesophageal echocardiography and intrapulmonary thrombolysis. Chest 1997; 112: 1310–6.
Wittlich N, Erbel R, Eichler A, Schuster S, Jakob H, Iversen S, Oelert H, Meyer J. Detection of central pulmonary thromboemboli by transesophageal echocardiography in patients with severe pulmonary embolism. J Am Soc Echocardiogr 1992; 5: 515–24.
Podbregar M, Krivec B, Voga G. Impact of morphologic charactersitics of central pulmonary thromboemboli in massive pulmonary embolism. Chest 2002; 122: 973–9.
Dorman P, Dennis M, Sandercock P. Are the modified simple questions a valid and reliable measure of health related quality of life after stroke? J Neur Neurosurg Psych 2000; 69: 487–92.
Myers J, Do D, Herbert W, Ribisl P, Froelicher VF. A normogram to predict exercise capacity from a specific activity questionnaire. Am J Cardiol 1994; 73: 591–6.
The EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199–208.
Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota living with heart failure questionnaire: reliability and validity during a randomised, duble-blind, placebo-controlled trial of pimobendan. Am Heart J 1992; 124: 1017–24.
Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 785–90.
Okubadejo AA, Jones PW, Wedzicha JA. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxemia. Thorax 1996; 51: 44–7.
Guyat GH, Thompson PJ, Berman LB, Sullivan MJ, Townsend M, Jones NL, Pugsley SO. J Chron Dis 1985; 38: 517–24.
Maille AR, Koning CJM, Zwinderman AH, Willems LNA, Dijkman JH, Kaptein AA. Quality of life in severe chronic obstructive pulmonary disease correlation with lung and muscle function. Respir Med 1997; 91: 297–309.
Monso E, Fiz JM, Izquierdo J, Alonso J, Coll R, Rosell A, Morera J. Quality of life in severe severe chronic obstructive pulmonary disease: correlation with lung and muscle function. Respir Med 1998; 92: 221–7.
Ferrer M, Alonso J, Morera J et al. Chronic obstructive pulmonary disease stage and health related quality of life. Ann Intern Med 1997; 127: 1072–9.
Dorman PJ, Waddel F, Slattery J, Dennis M, Sandercock P. Are proxy assessments of health status after stroke with EuroQool questionnaire feasible, accurate and unbiased? Stroke 1997; 28: 1883–7.
Alonso J, Permanyer-Miralda G, Cascant P, Brotons C, Prieto L, Soler-Soler J. Measuring functional status of chronic coronary patients. Eur Heart J 1997; 18: 414–9.
Rector TS, Cohn JN. Assessment of patient outcome with the Minesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J 1992; 124: 1017–7.
Wilson IB, Cleary PD. Linking clinical variables with health related quality of life. A conceptual model of patient outcomes. Jama 1995; 273: 59–65.
Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622–9.
Hlatky MA, Boineau MA, Higginbotham MB, Lee KL, Mark DB, Califf RM, Cobb FR, Pryor DB. A brief self-administred questionnaire to determine functional capacity (The Duke Activity Status Index). Am J Cardiol 1989; 64: 651–4.
Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998; 105: 91–9.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
